Heart health concerns prompt Pfizer to stop advertising Celebrex pain drug

NEW YORK (AP) - The maker of bestselling arthritis pain reliever Celebrex said it plans to immediately stop advertising the drug. The move comes after a study showed high doses of Celebrex were associated with an increased heart attack risk. New York-based Pfizer Inc....More